<DOC>
	<DOCNO>NCT00711360</DOCNO>
	<brief_summary>The new BIOTRONIK implantable cardioverter defibrillator ( ICD ) family Lumax 540 capable measure intrathoracic impedance daily basis transmission impedance trend data via Home Monitoring technology . In future , allow automatic early detection imminent decompensation presymptomatic stage immediate initialization clinical meaningful therapeutic intervention prevent heart failure relate hospitalization . The aim investigation record long-term impedance trend heart failure patient without heart failure relate event ( hospitalization due acute decompensation ) order develop algorithms device-based early detection warn HF deterioration accompany pulmonary congestion .</brief_summary>
	<brief_title>Monitoring Fluid Status Heart Failure Patients Intrathoracic Impedance Measurement ( HomeCARE II )</brief_title>
	<detailed_description>The new BIOTRONIK implantable cardioverter defibrillator ( ICD ) family Lumax 540 capable measure intrathoracic impedance daily basis transmission impedance trend data via Home Monitoring technology . In future , allow automatic early detection imminent decompensation presymptomatic stage immediate initialization clinical meaningful therapeutic intervention prevent heart failure relate hospitalization . The aim investigation record long-term impedance trend heart failure patient without heart failure relate event ( hospitalization due acute decompensation ) order develop algorithms device-based early detection warn HF deterioration accompany pulmonary congestion . Lumax name family implantable ICDs . The primary objective therapy prevention sudden cardiac death . The aim automatically detect terminate cardiac arrest cause ventricular tachyarrhythmia . All major therapeutical approach field cardiology electrophysiology contain within Lumax family . Furthermore , device capable treat bradycardia arrhythmia congestive heart failure . Congestive heart failure treat cardiac resynchronization therapy multisite ventricular pace know cardiac resynchronization therapy ( CRT ) . The integrated Home Monitoring component provide information occur rhythm disturbance deliver therapy close real time well intracardiac electrogram ( IEGM ) Online HDÂ® . Furthermore , statistical data patient 's condition well information integrity status implant sent . The implantation ICD symptomatic therapy follow objective : - Termination spontaneous ventricular fibrillation ( VF ) shock delivery - Termination spontaneous ventricular tachycardia ( VT ) mean antitachycardia pacing ( ATP ) ; case ineffective ATP hemodynamically tolerate VT shock delivery - Cardiac resynchronization multisite ventricular pacing ( triple-chamber implant ) - Compensation bradycardia ventricular ( single-chamber implant ) atrioventricular sequential pacing ( dual- triple-chamber implant )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Patient eligible 1 , 2 3chamber ICD implantation accord current guideline patient already implant Lumax 540 device successor NYHAclass II IV LVEF low equal 35 % Patient accept Home Monitoring concept sufficient GSM/GPRS net coverage Increased risk HFrelated hospitalization accord predefined criteria Patient information Informed consent Age &lt; 18 year Contraindication ICD implantation Post HTX actively list HTX Cardiac surgery within previous 3 month plan time inclusion Acute coronary syndrome within previous 3 month Chronic renal dialysis Pregnant breastfeed woman Limited contractual capability Participation another study Anticipated noncompliance followup scheme Life expectancy longer 1.5 year due noncardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>heart failure</keyword>
	<keyword>implantable cardioverter-defibrillator</keyword>
	<keyword>intrathoracic impedance</keyword>
	<keyword>cardiac resynchronization therapy</keyword>
	<keyword>home monitoring</keyword>
</DOC>